But I think with any project, especially one as sensitive as patient drug safety, time on market and the credibility of the individuals involved is key. We do have a medical doctor with FDA experience who advises DrugCite and has played a key role in the development phase. Honestly I know quite a bit about the other companies in this space, and we're really the only one where all of the players have worked in the medical informatics field for more than a decade each, and has an ex-FDA medical doctor advising the project. Once we post full disclosure on the site, hopefully this will help resolve some of the concerns you've raised. Thanks for the insight; I do hope we end up following Wikipedia's lead on this. And hopefully you'll feel comfortable recommending us in the future ;) Thanks again.